Intervention:   imipramine          

    Access protocols via the Procedure column.
Data set MPD ID Procedure / Protocol Drug or Challenge Phenotype Measure Panel No. of Strains Sex Age Sample Size (Avg) Year
    Gershenfeld1 16203 tail suspension test imipramine TST duration of immobility, treatment group   [s]     baseline    imipramine 30mg/kg inbred 12 m 5-10wks N=5 2003
    Gershenfeld1 16205 tail suspension test imipramine TST immobility percentage, imipramine vs. saline   [%]  TST_immobility_pct inbred 12 m 5-10wks N=5 2003
    Gershenfeld1 16210 light-dark box imipramine number of transitions between light and
dark compartments in 10 min   [n]
    baseline    imipramine 30mg/kg
inbred 12 m 5-10wks N=5 2003
    Gershenfeld1 16212 open field test imipramine distance traveled in 5 min   [cm]     baseline    imipramine 30mg/kg inbred 12 m 5-10wks N=5 2003
    Gershenfeld1 16214 open field test imipramine vertical movements (rearing) in 15 min   [n]     baseline    imipramine 30mg/kg inbred 12 m 5-10wks N=5 2003
    Gershenfeld1 16216 open field test imipramine average center time, 2 trials   [s]     baseline    imipramine 30mg/kg inbred 12 m 5-10wks N=5 2003
    Gershenfeld1 16218 open field test imipramine number of fecal boli in 15 min   [n]     baseline    imipramine 30mg/kg inbred 12 m 5-10wks N=5 2003
    All boxes